pubmed-article:21393187 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21393187 | lifeskim:mentions | umls-concept:C0038410 | lld:lifeskim |
pubmed-article:21393187 | lifeskim:mentions | umls-concept:C0282215 | lld:lifeskim |
pubmed-article:21393187 | lifeskim:mentions | umls-concept:C0282563 | lld:lifeskim |
pubmed-article:21393187 | lifeskim:mentions | umls-concept:C0949665 | lld:lifeskim |
pubmed-article:21393187 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
pubmed-article:21393187 | lifeskim:mentions | umls-concept:C0453882 | lld:lifeskim |
pubmed-article:21393187 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:21393187 | pubmed:dateCreated | 2011-3-15 | lld:pubmed |
pubmed-article:21393187 | pubmed:abstractText | Streptococcus pneumoniae has shown a great ability to develop efficacious mechanisms of resistance to the main drugs for the treatment of pneumonia, such as ?-lactams, macrolides and fluoroquinolones. The present study aimed to compare the antipneumococcal activity of combinations of respiratory fluoroquinolones with cephalosporins (either parenteral or oral) or protected penicillin versus the standard combinations (i.e. a macrolide with a protected penicillin or cephalosporin) against 100 isolates with different susceptibilities to macrolides and/or penicillin. | lld:pubmed |
pubmed-article:21393187 | pubmed:language | eng | lld:pubmed |
pubmed-article:21393187 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21393187 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21393187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21393187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21393187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21393187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21393187 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21393187 | pubmed:month | Apr | lld:pubmed |
pubmed-article:21393187 | pubmed:issn | 1460-2091 | lld:pubmed |
pubmed-article:21393187 | pubmed:author | pubmed-author:MattinaRR | lld:pubmed |
pubmed-article:21393187 | pubmed:author | pubmed-author:LarosaMM | lld:pubmed |
pubmed-article:21393187 | pubmed:author | pubmed-author:DragoLL | lld:pubmed |
pubmed-article:21393187 | pubmed:author | pubmed-author:De VecchiEE | lld:pubmed |
pubmed-article:21393187 | pubmed:author | pubmed-author:RodighieroVV | lld:pubmed |
pubmed-article:21393187 | pubmed:author | pubmed-author:NicolaLL | lld:pubmed |
pubmed-article:21393187 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21393187 | pubmed:volume | 66 | lld:pubmed |
pubmed-article:21393187 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21393187 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21393187 | pubmed:pagination | 845-9 | lld:pubmed |
pubmed-article:21393187 | pubmed:meshHeading | pubmed-meshheading:21393187... | lld:pubmed |
pubmed-article:21393187 | pubmed:meshHeading | pubmed-meshheading:21393187... | lld:pubmed |
pubmed-article:21393187 | pubmed:meshHeading | pubmed-meshheading:21393187... | lld:pubmed |
pubmed-article:21393187 | pubmed:meshHeading | pubmed-meshheading:21393187... | lld:pubmed |
pubmed-article:21393187 | pubmed:meshHeading | pubmed-meshheading:21393187... | lld:pubmed |
pubmed-article:21393187 | pubmed:meshHeading | pubmed-meshheading:21393187... | lld:pubmed |
pubmed-article:21393187 | pubmed:meshHeading | pubmed-meshheading:21393187... | lld:pubmed |
pubmed-article:21393187 | pubmed:meshHeading | pubmed-meshheading:21393187... | lld:pubmed |
pubmed-article:21393187 | pubmed:meshHeading | pubmed-meshheading:21393187... | lld:pubmed |
pubmed-article:21393187 | pubmed:meshHeading | pubmed-meshheading:21393187... | lld:pubmed |
pubmed-article:21393187 | pubmed:meshHeading | pubmed-meshheading:21393187... | lld:pubmed |
pubmed-article:21393187 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21393187 | pubmed:articleTitle | Comparative evaluation of synergy of combinations of beta-lactams with fluoroquinolones or a macrolide in Streptococcus pneumoniae. | lld:pubmed |
pubmed-article:21393187 | pubmed:affiliation | Laboratory of Clinical Chemistry and Microbiology, IRCCS Galeazzi Orthopaedic Institute, Milan, Italy. lorenzo.drago@unimi.it | lld:pubmed |
pubmed-article:21393187 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21393187 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:21393187 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |